TABLE 4.
Laboratory parameters | All patients (n = 95) | Disease severity | ||
---|---|---|---|---|
Non‐severe patients (n = 65) | Severe patients (n = 30) | P value | ||
Lymphocytes (×109/L; normal range 1.1‐3.2) | 1.05 (0.64‐1.50) | 1.24 (0.79‐1.68) | 0.77 (0.48‐1.24) | <.01 |
Lymphocyte percentage (%; normal range 20‐50) | 20.9 (14.8‐26.6) | 23.6 (17.6‐28.9) | 15.5 (7.93‐19.1) | <.01 |
Procalcitonin (PCT) (ng/mL; normal range 0‐0.1) | 0.02 (0.01‐0.03) | 0.02 (0.02‐0.03) | 0.03 (0.02‐0.05) | <.05 |
C‐reactive protein (CRP) (mg/L; normal range 0‐3) | 14.0 (5.62‐32.1) | 8.90 (4.85‐16.7) | 33.8 (19.3‐55.0) | <.01 |
CD4/CD8 ratio( normal range 1.4‐2.0) | 1.54 (1.08‐2.27) | 1.59 (1.28‐2.27) | 1.46 (0.74‐2.33) | >.05 |
Eosinophils (×109/L; normal range 0.05‐0.5) | 0.01 (0.0‐0.04) | 0.02 (0.01‐0.06) | 0.01 (0.0‐0.01) | <.01 |
Eosinophil percentage (%; normal range 0.5%‐5%) | 0.3 (0.1‐0.8) | 0.4 (0.1‐1.0) | 0.1 (0.0‐0.33) | <.01 |
P values denoted the comparison between non‐severe and severe subgroups.